July 2021 Chimeric licenses novel solid tumor CAR T therapy from world-renowned cell therapy centre the University of Pennsylvania
June 2021 Dr Li Ren, a Senior CAR T Executive from BMS, joins Chimeric Therapeutics as Vice President, Technical Operations.
April 2021 Successful completion of 28-day follow-up period for first patient cohort in CLTX CAR T Phase 1 trial
February 2021 Dr Eliot Bourk, former Kite Pharma Senior Executive, joins Chimeric as VP Business & Corporate Development
September 2021 ASX Small and Mid Cap Conference – Jennifer Chow, Chimeric CEO – Tuesday, September 14
September 2021 H.C. Wainwright 23rd Annual Global Investment Conference – Sep 13, 2021 at 7:30 AM EDT (presentation materials and associated webcasts will be posted on the company’s website on September 13)
July 2021 Corporate Presentation: Exclusive Licensing of CDH17 CAR T Cell Therapy from the University of Pennsylvania
March 2021 Chimeric Therapeutics new very experienced COO has bold vision to move CAR T cell therapy forward
March 2021 Renowned biotech entrepreneur Paul Hopper on raising money, picking biotech winners and his latest ASX venture
March 2021 Cancer-free after 12 years: Why you’re hearing the C-word more often – Australian Financial Review Magazine
